Live feed
Filing
SC 13G
SC 13G0001929354-22-000002·Avalo Therapeutics, Inc.
Schedule 13G ownership disclosure
Avalo Therapeutics, Inc.
Security class unavailable · CUSIP: 05338F108
Event date: 2022-05-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,100,000
- Percent of class
- 3.6300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001929354-22-000002
- Form type
- SC 13G
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- May 17, 2022
- Reporting period
- May 04, 2022
- Description
- Schedule 13G beneficial ownership